Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva

CompletedOBSERVATIONAL
Enrollment

5,197

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

June 9, 2021

Study Completion Date

June 9, 2021

Conditions
SARS-CoV-2 InfectionCOVID-19
Interventions
DIAGNOSTIC_TEST

Nasopharyngeal swab

Research of SARS-CoV-2 infection in nasopharyngeal swab by RT-PCR and by antigenic test

DIAGNOSTIC_TEST

Saliva sample

Research of SARS-CoV-2 infection in saliva samples by RT-PCR and by new detection approach

DIAGNOSTIC_TEST

axillary sweat sample

Research of volatile olfactory compounds of SARS-CoV-2 infection by canine detection on axillary sweat.

OTHER

Data collection

Demographics, symptoms, medical history, acceptability of specimen, consumption in precedents hours are collected

Trial Locations (1)

75001

SARS-CoV-2 screening device of Assistance Publique des Hôpitaux de Paris (AP-HP), Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04578509 - Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva | Biotech Hunter | Biotech Hunter